Baricitinib for rheumatoid arthritis
Baricitinib is a substance that reduces the immune system response, decreasing the action of enzymes that promote inflammation and joint damage in rheumatoid arthritis, so this remedy is able to reduce inflammation, relieving symptoms of the disease such as joint pain and swelling. However, this drug is not yet approved in Brazil by Anvisa, nor […]